Effectiveness of polymyxin B hemoperfusion for sepsis depends on the baseline SOFA score: a nationwide observational study

BACKGROUND: Polymyxin B hemoperfusion (PMX) aims to treat septic shock by removing endotoxin from the patient’s blood. However, the relationship between the severity of the patient's organ damage and the survival benefit of PMX treatment is not clear. METHODS: We analyzed the efficacy of PMX on...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujimori, Kenji, Tarasawa, Kunio, Fushimi, Kiyohide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473472/
https://www.ncbi.nlm.nih.gov/pubmed/34568980
http://dx.doi.org/10.1186/s13613-021-00928-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473472/
https://www.ncbi.nlm.nih.gov/pubmed/34568980
http://dx.doi.org/10.1186/s13613-021-00928-z

Ejemplares similares